leflunomide has been researched along with Neoplasm Metastasis in 1 studies
Leflunomide: An isoxazole derivative that inhibits dihydroorotate dehydrogenase, the fourth enzyme in the pyrimidine biosynthetic pathway. It is used an immunosuppressive agent in the treatment of RHEUMATOID ARTHRITIS and PSORIATIC ARTHRITIS.
leflunomide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 5-methyl-1,2-oxazole-4-carboxylic acid with the anilino group of 4-(trifluoromethyl)aniline. The prodrug of teriflunomide.
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, R | 1 |
| Liu, B | 1 |
| Liu, X | 1 |
| Fan, Y | 1 |
| Peng, W | 1 |
| Huang, C | 1 |
| Marcus, A | 1 |
| Sica, G | 1 |
| Gilbert-Ross, M | 1 |
| Liu, Y | 1 |
| Zhou, W | 1 |
1 other study available for leflunomide and Neoplasm Metastasis
| Article | Year |
|---|---|
Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis.
Topics: Enzyme Inhibitors; Humans; Immune Tolerance; Leflunomide; Neoplasm Metastasis; Neoplasms | 2021 |